Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)

被引：0
|
作者：
Koki Nakanishi
Daisuke Kobayashi
Yoshinari Mochizuki
Kiyoshi Ishigure
Seiji Ito
Hiroshi Kojima
Akiharu Ishiyama
Shinichi Fujitake
Toshio Shikano
Satoshi Morita
Yasuhiro Kodera
机构：
[1] Komaki City Hospital,Department of Surgery
[2] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery
[3] Konan Kosei Hospital,Department of Surgery
[4] Aichi Cancer Center,Department of Gastroenterological Surgery
[5] Aichi Cancer Center Hospital,Department of Surgery
[6] Okazaki City Hospital,Department of Surgery
[7] Nishio Municipal Hospital,Department of Surgery
[8] Yokkaichi Municipal Hospital,Department of Surgery
[9] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Gastric cancer; S-1; Paclitaxel; Second-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：557 / 565
页数：8
相关论文
共 50 条
  • [31] Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer
    Jin Young Kim
    Young Rok Do
    Keon Uk Park
    Jong Gwang Kim
    Yee Soo Chae
    Min Kyoung Kim
    Kyung Hee Lee
    Hun Mo Ryoo
    Sung Hwa Bae
    Jin Ho Baek
    Hong Suk Song
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 527 - 532
  • [32] Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer
    Kim, Jin Young
    Do, Young Rok
    Park, Keon Uk
    Kim, Jong Gwang
    Chae, Yee Soo
    Kim, Min Kyoung
    Lee, Kyung Hee
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Baek, Jin Ho
    Song, Hong Suk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 527 - 532
  • [33] Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel as first-line chemotherapy for patients with metastatic gastric cancer
    Xu, Rui-hua
    He, Ming-ming
    Zhang, Dong-sheng
    Wang, Feng
    Jin, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] A randomized phase III study of S-1 alone versus S-1 plus immunomodulator lentinan for unresectable or recurrent gastric cancer (JFMC36-0701)
    Nishikawa, K.
    Yoshino, S.
    Morita, S.
    Takahashi, T.
    Sakata, K.
    Nagao, J.
    Nemoto, H.
    Murakami, N.
    Matsuda, T.
    Hasegawa, H.
    Shimizu, R.
    Yoshikawa, T.
    Osanai, H.
    Imano, M.
    Naitoh, H.
    Yabe, M.
    Tanaka, A.
    Sakamoto, J.
    Saji, S.
    Oka, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S442 - S442
  • [35] Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
    Dai, Yu-Hong
    Yu, Xiong-Jie
    Xu, Hui-Ting
    Zhuang, Liang
    Zhang, Ming-Sheng
    Zou, Yan-Mei
    Fu, Qiang
    Qiu, Hong
    Yuan, Xiang-Lin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [36] Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer
    Mochiki, E.
    Ogata, K.
    Ohno, T.
    Toyomasu, Y.
    Haga, N.
    Fukai, Y.
    Aihara, R.
    Ando, H.
    Uchida, N.
    Asao, T.
    Kuwano, H.
    BRITISH JOURNAL OF CANCER, 2012, 107 (01) : 31 - 36
  • [37] Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer
    E Mochiki
    K Ogata
    T Ohno
    Y Toyomasu
    N Haga
    Y Fukai
    R Aihara
    H Ando
    N Uchida
    T Asao
    H Kuwano
    British Journal of Cancer, 2012, 107 : 31 - 36
  • [38] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701
    Kawase, Tomono
    Imamura, Hiroshi
    Goto, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Kawakami, Hisato
    Sakai, Daisuke
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (10) : 1871 - 1880
  • [39] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701
    Tomono Kawase
    Hiroshi Imamura
    Masahiro Goto
    Yutaka Kimura
    Shugo Ueda
    Jin Matsuyama
    Kazuhiro Nishikawa
    Naotoshi Sugimoto
    Junya Fujita
    Takao Tamura
    Norimasa Fukushima
    Hisato Kawakami
    Daisuke Sakai
    Yukinori Kurokawa
    Toshio Shimokawa
    Taroh Satoh
    International Journal of Clinical Oncology, 2021, 26 : 1871 - 1880
  • [40] Intraperitoneal and intravenous paclitaxel plus S-1 versus intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis: Results from the multicenter, randomized, phase 3 DRAGON-01 trial.
    Yang, Zhongyin
    Shi, Zheng
    Lu, Sheng
    Shi, Min
    Nie, Mingming
    Chen, Jian
    Wu, Dan
    Mou, Yiping
    Xu, Yunyun
    Wang, Yanong
    Liu, Xiaowen
    Cao, Hui
    Gu, Jiayi
    Yu, Jiren
    Liu, Kai
    Liu, Xinchun
    Zhang, Jun
    Yin, Kai
    Zhu, Zhenggang
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 327 - 327
12345